Shandong Weigao Group Announces Leadership Change

The latest announcement is out from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ).

Shandong Weigao Group Medical Polymer Company Limited announced a change in its board leadership effective 28 May 2025. Mr. Tang Zhengpeng has resigned as Vice-Chairman but will continue his role as a non-executive Director and committee member. Ms. Yan Xia, previously a non-executive Director, will succeed him as Vice-Chairman. This leadership transition is part of the company’s strategic reassignment of duties and responsibilities, potentially impacting its governance and stakeholder relations.

The most recent analyst rating on (HK:1066) stock is a Buy with a HK$6.40 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a joint stock limited company incorporated in the People’s Republic of China. The company operates in the medical polymer industry, focusing on the production and distribution of medical devices and equipment. It is listed on the Hong Kong Stock Exchange under the stock code 1066.

Average Trading Volume: 10,817,723

Technical Sentiment Signal: Hold

Current Market Cap: HK$25.55B

For detailed information about 1066 stock, go to TipRanks’ Stock Analysis page.